Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Margaret A Knowles

Showing results (1-10 of 110) with videos related to

Pageof 11
Sort By:
World Journal of Urology|October 4, 2007
Role of FGFR3 in urothelial cell carcinoma: biomarker and potential therapeutic targetMargaret A Knowles
Scandinavian Journal of Urology and Nephrology. Supplementum|December 5, 2008
Bladder cancer subtypes defined by genomic alterationsMargaret A Knowles
Future Oncology (London, England)|February 5, 2008
Novel therapeutic targets in bladder cancer: mutation and expression of FGF receptorsMargaret A Knowles
Carcinogenesis|December 15, 2005
Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?Margaret A Knowles
Frontiers in Bioscience : a Journal and Virtual Library|November 28, 2006
Tumor suppressor loci in bladder cancerMargaret A Knowles
International Journal of Clinical Oncology|August 16, 2008
Molecular pathogenesis of bladder cancerMargaret A Knowles
Urologic Oncology|July 9, 2010
Bladder cancer or bladder cancers? Genetically distinct malignant conditions of the urotheliumPeter J Goebell, Margaret A Knowles
Molecular Carcinogenesis|July 24, 2009
Necdin: a multi functional protein with potential tumor suppressor role?Emma J Chapman, Margaret A Knowles
Cancer Cell|February 15, 2014
Molecular subtyping of invasive bladder cancer: time to divide and rule?Carolyn D Hurst, Margaret A Knowles
The Journal of Molecular Diagnostics : JMD|October 28, 2004
Measurement of relative copy number of CDKN2A/ARF and CDKN2B in bladder cancer by real-time quantitative PCR and multiplex ligation-dependent probe amplificationJoanne S Aveyard, Margaret A Knowles
Pageof 11

Showing results (1-10 of 110) with videos related to

Sort By:
Pageof 11
World Journal of Urology|October 4, 2007
Role of FGFR3 in urothelial cell carcinoma: biomarker and potential therapeutic targetMargaret A Knowles
Scandinavian Journal of Urology and Nephrology. Supplementum|December 5, 2008
Bladder cancer subtypes defined by genomic alterationsMargaret A Knowles
Future Oncology (London, England)|February 5, 2008
Novel therapeutic targets in bladder cancer: mutation and expression of FGF receptorsMargaret A Knowles
Carcinogenesis|December 15, 2005
Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?Margaret A Knowles
Frontiers in Bioscience : a Journal and Virtual Library|November 28, 2006
Tumor suppressor loci in bladder cancerMargaret A Knowles
International Journal of Clinical Oncology|August 16, 2008
Molecular pathogenesis of bladder cancerMargaret A Knowles
Urologic Oncology|July 9, 2010
Bladder cancer or bladder cancers? Genetically distinct malignant conditions of the urotheliumPeter J Goebell, Margaret A Knowles
Molecular Carcinogenesis|July 24, 2009
Necdin: a multi functional protein with potential tumor suppressor role?Emma J Chapman, Margaret A Knowles
Cancer Cell|February 15, 2014
Molecular subtyping of invasive bladder cancer: time to divide and rule?Carolyn D Hurst, Margaret A Knowles
The Journal of Molecular Diagnostics : JMD|October 28, 2004
Measurement of relative copy number of CDKN2A/ARF and CDKN2B in bladder cancer by real-time quantitative PCR and multiplex ligation-dependent probe amplificationJoanne S Aveyard, Margaret A Knowles
Pageof 11